Cargando…

The impact of COVID-19 and the restoration of tuberculosis services in the Western Pacific Region

While COVID-19 has imposed great challenges to national tuberculosis programmes, it has also created opportunities to develop innovative strategies to ensure continuity of TB services and ultimately to strengthen TB care, prevention and control https://bit.ly/3bHDQx0

Detalles Bibliográficos
Autores principales:	Chiang, Chen-Yuan, Islam, Tauhid, Xu, Caihong, Chinnayah, Thilaka, Garfin, Anna Marie Celina, Rahevar, Kalpeshsinh, Raviglione, Mario
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2020
Materias:	Agora
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7518076/ https://www.ncbi.nlm.nih.gov/pubmed/32978310 http://dx.doi.org/10.1183/13993003.03054-2020

Ejemplares similares

Epidemiological review of leprosy in WHO’s Western Pacific Region: 1991–2019
por: Rahevar, Kalpeshsinh, et al.
Publicado: (2021)

Financing for tuberculosis prevention, diagnosis and treatment services in the Western Pacific Region in 2005–2020
por: Morishita, Fukushi, et al.
Publicado: (2023)

Evaluation of the 2016–2020 regional tuberculosis response framework, WHO Western Pacific Region
por: Viney, Kerri, et al.
Publicado: (2021)

Epidemiology of tuberculosis in the Western Pacific Region: Progress towards the 2020 milestones of the End TB Strategy
por: Morishita, Fukushi, et al.
Publicado: (2020)

Progress on diagnosis and treatment of drug-resistant tuberculosis in line with World Health Organization recommendations in six priority countries in the Western Pacific Region
por: Oh, Kyung Hyun, et al.
Publicado: (2022)

Tuberculosis outbreaks in schools: Experiences from the Western Pacific Region
por: Rahevar, Kalpeshsinh, et al.
Publicado: (2021)

Tuberculosis in the Western Pacific Region: Estimating the burden of disease and return on investment 2020–2030 in four countries
por: Estill, Janne, et al.
Publicado: (2021)

Numbers needed to treat to prevent tuberculosis
por: Matteelli, Alberto, et al.
Publicado: (2015)

Clinical characteristics of COVID-19 and active tuberculosis co-infection in an Italian reference hospital
por: Stochino, Claudia, et al.
Publicado: (2020)

Tuberculosis in older adults: challenges and best practices in the Western Pacific Region
por: Teo, Alvin Kuo Jing, et al.
Publicado: (2023)

Impact of the COVID-19 pandemic on tuberculosis laboratory services in Europe
por: Nikolayevskyy, Vladyslav, et al.
Publicado: (2021)

Gauging the impact of the COVID-19 pandemic on tuberculosis services: a global study
por: Migliori, Giovanni Battista, et al.
Publicado: (2021)

Variation in policy and practice of adolescent tuberculosis management in the WHO European Region
por: Blok, Nick, et al.
Publicado: (2016)

Tuberculosis in older adults: case studies from four countries with rapidly ageing populations in the western pacific region
por: Teo, Alvin Kuo Jing, et al.
Publicado: (2023)

Epidemiology of tuberculosis in the Pacific island countries and areas, 2000–2020
por: Yanagawa, Manami, et al.
Publicado: (2023)

Strengthening national, regional and global health capacity through the WHO Western Pacific Region’s Field Epidemiology Fellowship Programme
por: Togami, Eri, et al.
Publicado: (2021)

Correction: Tuberculosis in older adults: case studies from four countries with rapidly ageing populations in the western pacific region
por: Teo, Alvin Kuo Jing, et al.
Publicado: (2023)

Supporting progress towards the post-2015 targets and regional tuberculosis elimination: a statement of intent from the third meeting of the Asian TB Experts Community
por: Mori, Toru, et al.
Publicado: (2015)

Intensified research on tuberculosis in the Western Pacific Region: a bibliometric analysis, 2000–2019
por: Morishita, Fukushi, et al.
Publicado: (2020)

On tuberculosis and COVID-19 co-infection
por: Tadolini, Marina, et al.
Publicado: (2020)

Tuberculosis contact investigation in an intermediate burden setting: implications from a large tuberculosis contact cohort in Taiwan
por: Lee, Meng-Rui, et al.
Publicado: (2017)

Practices of therapeutic drug monitoring in tuberculosis: an international survey
por: Margineanu, Ioana, et al.
Publicado: (2022)

Global reporting on tuberculosis preventive treatment among contacts
por: Falzon, Dennis, et al.
Publicado: (2022)

Tuberculosis prevention must integrate technological and basic care innovation
por: Mason, Paul H., et al.
Publicado: (2016)

Eligibility for shorter treatment of multidrug-resistant tuberculosis in the European Union
por: van der Werf, Marieke J., et al.
Publicado: (2017)

The potential impact of COVID-19-related disruption on tuberculosis burden
por: McQuaid, C. Finn, et al.
Publicado: (2020)

Insight into the impact of the COVID-19 epidemic on tuberculosis burden in China
por: Chen, Hongguang, et al.
Publicado: (2020)

QIAreach QuantiFERON-TB for the diagnosis of Mycobacterium tuberculosis infection
por: Saluzzo, Francesca, et al.
Publicado: (2022)

Bedaquiline resistance in drug-resistant tuberculosis HIV co-infected patients
por: Nimmo, Camus, et al.
Publicado: (2020)

Long-term mortality assessment of multidrug-resistant tuberculosis patients treated with delamanid
por: Wells, Charles D., et al.
Publicado: (2015)

First case of extensively drug-resistant tuberculosis treated with both delamanid and bedaquiline
por: Tadolini, Marina, et al.
Publicado: (2016)

Rifapentine access in Europe: growing concerns over key tuberculosis treatment component
por: Guglielmetti, Lorenzo, et al.
Publicado: (2022)

Video-observed treatment for tuberculosis patients in Belarus: findings from the first programmatic experience
por: Sinkou, Heorhi, et al.
Publicado: (2017)

Impact of the SARS-CoV-2 epidemic on tuberculosis treatment outcome in Northern Italy
por: Magro, Paola, et al.
Publicado: (2020)

Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases
por: Tadolini, Marina, et al.
Publicado: (2020)

Cycloserine did not increase depression incidence or severity at standard dosing for multidrug-resistant tuberculosis
por: Tornheim, Jeffrey A., et al.
Publicado: (2022)

Cross border, highly individualised treatment of a patient with challenging extensively drug-resistant tuberculosis
por: Akkerman, Onno W., et al.
Publicado: (2018)

A profile of a retrospective cohort of 22 patients with COVID-19 and active/treated tuberculosis
por: Gupta, Nitesh, et al.
Publicado: (2020)

Wider access to quality-assured rifapentine-based regimens is needed to accelerate tuberculosis prevention and care globally
por: Masini, Tiziana, et al.
Publicado: (2022)

Monitoring toxicity in individuals receiving treatment for latent tuberculosis infection: a systematic review versus expert opinion
por: Sotgiu, Giovanni, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_gk1cc378qqrsn02aafb5qs00v8